Nothing Special   »   [go: up one dir, main page]

EE04819B1 - Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk - Google Patents

Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk

Info

Publication number
EE04819B1
EE04819B1 EEP199900272A EEP9900272A EE04819B1 EE 04819 B1 EE04819 B1 EE 04819B1 EE P199900272 A EEP199900272 A EE P199900272A EE P9900272 A EEP9900272 A EE P9900272A EE 04819 B1 EE04819 B1 EE 04819B1
Authority
EE
Estonia
Prior art keywords
host cell
expression vector
recombinant dna
dna molecule
cell containing
Prior art date
Application number
EEP199900272A
Other languages
English (en)
Inventor
Revel Michel
Abramovitch Carolina
Chebath Judith
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900272A publication Critical patent/EE9900272A/et
Publication of EE04819B1 publication Critical patent/EE04819B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1003Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007Methyltransferases (general) (2.1.1.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900272A 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk EE04819B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3563697P 1997-01-15 1997-01-15
PCT/US1998/000671 WO1998031796A1 (en) 1997-01-15 1998-01-15 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (2)

Publication Number Publication Date
EE9900272A EE9900272A (et) 2000-02-15
EE04819B1 true EE04819B1 (et) 2007-04-16

Family

ID=21883894

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900272A EE04819B1 (et) 1997-01-15 1998-01-15 Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk

Country Status (20)

Country Link
US (1) US7264945B2 (et)
EP (1) EP1019500B1 (et)
JP (1) JP4614473B2 (et)
KR (2) KR100591988B1 (et)
CN (1) CN1212398C (et)
AT (1) ATE342972T1 (et)
AU (1) AU731206C (et)
BG (1) BG64829B1 (et)
BR (1) BR9806755A (et)
CA (1) CA2276111A1 (et)
CZ (1) CZ299096B6 (et)
DE (1) DE69836226T2 (et)
DK (1) DK1019500T3 (et)
EA (1) EA003250B1 (et)
EE (1) EE04819B1 (et)
ES (1) ES2275297T3 (et)
IL (2) IL130960A0 (et)
NO (1) NO326104B1 (et)
UA (1) UA75560C2 (et)
WO (1) WO1998031796A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119129A1 (en) * 1997-01-15 2002-08-29 Yeda Research And Development Co. Ltd. Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
WO2003055506A1 (fr) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Medicaments pour la prevention et le traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220759A1 (de) * 1992-06-24 1994-01-05 Inst Genbiologische Forschung DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) * 1996-10-02 2001-06-05 The University Of North Carolina At Chapel Hill DNA molecules encoding a calcium-integrin binding protein

Also Published As

Publication number Publication date
EA199900663A1 (ru) 2000-02-28
AU731206B2 (en) 2001-03-29
CZ247199A3 (cs) 2000-01-12
EP1019500B1 (en) 2006-10-18
AU5824098A (en) 1998-08-07
JP4614473B2 (ja) 2011-01-19
IL130960A (en) 2008-03-20
KR20000070181A (ko) 2000-11-25
CN1243544A (zh) 2000-02-02
CA2276111A1 (en) 1998-07-23
EP1019500A4 (en) 2004-04-07
EE9900272A (et) 2000-02-15
US7264945B2 (en) 2007-09-04
BG64829B1 (bg) 2006-05-31
CN1212398C (zh) 2005-07-27
EA003250B1 (ru) 2003-02-27
ATE342972T1 (de) 2006-11-15
KR100591988B1 (ko) 2006-06-21
ES2275297T3 (es) 2007-06-01
AU731206C (en) 2002-05-16
KR100799828B1 (ko) 2008-01-31
KR20050046779A (ko) 2005-05-18
WO1998031796A8 (en) 1999-05-20
NO993412D0 (no) 1999-07-09
CZ299096B6 (cs) 2008-04-23
DK1019500T3 (da) 2007-02-19
WO1998031796A1 (en) 1998-07-23
DE69836226T2 (de) 2007-02-01
JP2001508306A (ja) 2001-06-26
EP1019500A2 (en) 2000-07-19
UA75560C2 (en) 2006-05-15
NO326104B1 (no) 2008-09-22
DE69836226D1 (de) 2006-11-30
IL130960A0 (en) 2001-01-28
BG103627A (en) 2000-04-28
US20030176678A1 (en) 2003-09-18
NO993412L (no) 1999-07-09
BR9806755A (pt) 2000-03-14

Similar Documents

Publication Publication Date Title
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
HUP0004639A2 (hu) Chlamydia fehérje, génszekvencia és ezek alkalmazása
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE69433240D1 (de) Apoptosegen von wirbeltieren, zusammensetzungen und verwendungen
DK0669929T3 (da) Elk-ligand, et cytokin
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
BR9507657A (pt) Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
DK0970213T3 (da) Dödsdomæneholdig receptor
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
NO20000934L (no) Adipocyttspesifikke proteinhomologer
ATE327328T1 (de) Adipozyten-spezifische protein homologe
ATE122394T1 (de) Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
EE04819B1 (et) Rekombinantne DNA molekul ja ekspressioonivektorit sisaldav peremeesrakk
DK193187A (da) Interferoninduceret humanprotein paa ren form, dets fremstilling og anvendlese
FI950516A0 (fi) Interferoni-alfa/beta-sitojaproteiini, sen valmistus ja käyttö
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
BR9810046A (pt) Sequência de nucleotìdeos, vetor de expressão, célula hospedeira, proteìna de esperma de mamìfero, proteìna de esperma recombinante, proteìna 4, 1 e/ou 6,7 de esperma, composição farmacêutica, e, vacina contraceptiva

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231